Post operative penicillin-non-susceptible Streptococcus pneumoniae meningitis and septic shock in a child

Pagakrong Lumbiganon1, Palakorn Surakunprapha, Pope Kosalaraksa

  • 1Department of Pediatrics, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. paglum@kku.ac.th

Insights

A rare case of post-operative meningitis in a child with fronto-ethmoidal encephalomeningocele was successfully treated. This highlights the importance of considering penicillin-non-susceptible Streptococcus pneumoniae in serious infections.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pediatric Surgery

Background:

  • Fronto-ethmoidal encephalomeningocele repair is a complex neurosurgical procedure.
  • Post-operative infections, including meningitis, are significant risks in pediatric neurosurgery.
  • Increasing prevalence of antibiotic-resistant bacteria poses a challenge to empirical treatment strategies.

Observation:

  • A one-year-old girl developed wound infection, purulent meningitis, and septic shock five hours after fronto-ethmoidal encephalomeningocele repair.
  • Cerebrospinal fluid and eye discharge cultures identified Streptococcus pneumoniae.
  • The isolate exhibited penicillin-non-susceptible characteristics (MIC of penicillin = 1.0 ug/ml).

Findings:

  • Empirical treatment with ceftazidime and vancomycin was initiated.
  • Antibiotic therapy was switched to cefotaxime (300 mg/kg/day) based on susceptibility testing.
  • The patient achieved a complete recovery following appropriate antibiotic management.

Implications:

  • Penicillin-non-susceptible Streptococcus pneumoniae should be considered in the differential diagnosis of severe post-operative infections of the face and neck.
  • This case underscores the need for vigilant monitoring and tailored antibiotic therapy in pediatric neurosurgical patients.
  • Awareness of rising penicillin resistance in S. pneumoniae is crucial for optimizing treatment outcomes in surgical site infections.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...